We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+5.65%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.01B
AUM Growth
+$205M
(+25%)
Cap. Flow
+$234M
Cap. Flow
% of AUM
23.15%
Top 10 Holdings %
Top 10 Hldgs %
4.25%
Holding
2,085
New
689
Increased
399
Reduced
339
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
National Vision
EYE
|
+$5.45M |
| 2 |
Altimmune
ALT
|
+$4.45M |
| 3 |
FRC
First Republic Bank
FRC
|
+$4.06M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.99M |
| 5 |
Hilton Worldwide
HLT
|
+$3.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$7.74M |
| 2 |
Dropbox
DBX
|
+$3.02M |
| 3 |
Progressive
PGR
|
+$2.77M |
| 4 |
Southwest Airlines
LUV
|
+$2.69M |
| 5 |
Transocean
RIG
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 14.87% |
| 3 | Healthcare | 14.13% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 11.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
S&T Bancorp
STBA
$1.79B
| $339K | 0.03% |
+10,794
| New | +$376K |
|
952
Chubb
CB
$135B
| $337K | 0.03% |
+1,735
| New | +$365K |
|
953
GameStop
GME
$8.6B
| $337K | 0.03% |
+14,618
| New | +$291K |
|
954
Ionis Pharmaceuticals
IONS
$9.4B
| $337K | 0.03% |
+9,422
| New | +$354K |
|
955
Wendy's
WEN
$1.46B
| $337K | 0.03% |
+15,473
| New | +$340K |
|
956
Northwest Natural Holdings
NWN
$2.12B
| $336K | 0.03% |
7,070
-7,207
| -50% | -$348K |
|
957
Stoke Therapeutics
STOK
$2.11B
| $336K | 0.03% |
40,364
-31,208
| -44% | -$282K |
|
958
Zymeworks
ZYME
$1.67B
| $335K | 0.03% |
37,093
+9,230
| +33% | +$80.5K |
|
959
AES
AES
$10.5B
| $334K | 0.03% |
+13,877
| New | +$353K |
|
|
AMED
960
DELISTED
Amedisys
AMED
| $334K | 0.03% |
4,542
-5,261
| -54% | -$455K |
|
961
Amphenol
APH
$209B
| $334K | 0.03% |
8,182
-2,844
| -26% | -$112K |
|
962
CorMedix
CRMD
$584M
| $334K | 0.03% |
80,641
-55,915
| -41% | -$229K |
|
|
NBP
963
NovaBridge Biosciences American Depositary Shares
NBP
$202M
| $334K | 0.03% |
96,555
-120,856
| -56% | -$585K |
|
964
NerdWallet
NRDS
$652M
| $334K | 0.03% |
+20,654
| New | +$311K |
|
965
Texas Capital Bancshares
TCBI
$4.32B
| $334K | 0.03% |
+6,819
| New | +$419K |
|
|
QUOT
966
DELISTED
Quotient Technology Inc
QUOT
| $334K | 0.03% |
101,756
-6,703
| -6% | -$23.8K |
|
967
Ingredion
INGR
$6.58B
| $333K | 0.03% |
+3,270
| New | +$326K |
|
968
LyondellBasell Industries
LYB
$19.2B
| $332K | 0.03% |
+3,533
| New | +$329K |
|
969
RPC Inc
RES
$1.3B
| $332K | 0.03% |
43,184
+8,323
| +24% | +$74K |
|
|
TSE
970
DELISTED
Trinseo
TSE
| $332K | 0.03% |
15,942
-1,058
| -6% | -$25.9K |
|
|
EGIO
971
DELISTED
Edgio, Inc. Common Stock
EGIO
| $332K | 0.03% |
10,477
-1,709
| -14% | -$84.2K |
|
972
Brookfield Infrastructure
BIPC
$4.85B
| $330K | 0.03% |
+7,158
| New | +$312K |
|
|
AXNX
973
DELISTED
Axonics, Inc. Common Stock
AXNX
| $328K | 0.03% |
6,016
-14,975
| -71% | -$875K |
|
974
Brookfield Renewable
BEPC
$6.26B
| $327K | 0.03% |
+9,363
| New | +$283K |
|
975
Carrier Global
CARR
$52.8B
| $327K | 0.03% |
+7,151
| New | +$320K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2023 Portfolio in Review
As of Q1 2023, GSA Capital Partners held 2,085 positions worth $1.01B, up 25% from $806M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
GSA Capital Partners deployed $234M of net new capital in Q1 2023, opening 689 new positions and adding to 399 existing holdings. Its largest new stake was National Vision: 167,499 shares worth $3.16M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Transocean, an estimated $2.59M trimmed.
- GSA Capital Partners's largest Q1 2023 buy was National Vision: 167,499 shares worth $3.16M.
- GSA Capital Partners added most to Altimmune in Q1 2023, an estimated $4.45M increase.
- GSA Capital Partners's biggest Q1 2023 reduction was Transocean, cutting an estimated $2.59M.
- GSA Capital Partners fully exited PG&E in Q1 2023, selling an estimated $7.74M.
- GSA Capital Partners's ten largest holdings make up 4.2% of its $1.01B portfolio in Q1 2023.
- GSA Capital Partners opened 689 new positions and closed 654 in Q1 2023.
- GSA Capital Partners's portfolio value rose 25% quarter-over-quarter to $1.01B.
Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.